[Form 4] Neuraxis, Inc. Insider Trading Activity
Kristin Ferge, a director of Neuraxis, Inc. (NRXS), reported a non-derivative acquisition of common stock on 01/17/2025. She acquired 13,157 shares at a price of $2.85 per share. Following this transaction, Ms. Ferge beneficially owned 14,340 shares. The filing states these shares were issued as compensation for services rendered as an independent director of the company. The Form 4 shows the filing is made by one reporting person and includes the reporting person’s address in Carmel, IN.
Kristin Ferge, membro del consiglio di amministrazione di Neuraxis, Inc. (NRXS), ha comunicato un acquisto non derivato di azioni ordinarie in data 17/01/2025. Ha acquisito 13.157 azioni al prezzo di $2,85 ciascuna. Dopo l’operazione, la Sig.ra Ferge deteneva beneficiariamente 14.340 azioni. Il documento specifica che le azioni sono state emesse come compenso per servizi resi in qualità di amministratore indipendente. Il Form 4 indica un solo soggetto dichiaratore e riporta l’indirizzo del dichiarante a Carmel, IN.
Kristin Ferge, directora de Neuraxis, Inc. (NRXS), informó una adquisición no derivada de acciones ordinarias el 17/01/2025. Adquirió 13.157 acciones a $2,85 por acción. Tras la operación, la Sra. Ferge poseía beneficiariamente 14.340 acciones. La presentación indica que estas acciones se emitieron como compensación por servicios prestados como directora independiente de la compañía. El Formulario 4 muestra que la presentación la realiza una sola persona informante e incluye su dirección en Carmel, IN.
Kristin Ferge, Neuraxis, Inc. (NRXS)의 이사로서 2025-01-17에 비파생(비파생성) 보통주 취득을 신고했습니다. 그녀는 주당 $2.85에 13,157주를 취득했습니다. 이 거래 후 Ferge 여사는 14,340주를 실질적으로 보유하게 되었습니다. 제출서에는 이 주식이 회사의 독립 이사로서 제공한 서비스에 대한 보수로 발행되었다고 명시되어 있습니다. Form 4는 한 명의 보고자가 제출했음을 표시하며 보고자의 주소가 인디애나주 카멜(Carmel, IN)로 기재되어 있습니다.
Kristin Ferge, administratrice de Neuraxis, Inc. (NRXS), a déclaré une acquisition non dérivée d’actions ordinaires le 17/01/2025. Elle a acquis 13 157 actions au prix de 2,85 $ par action. À l’issue de la transaction, Mme Ferge détenait bénéficiairement 14 340 actions. Le document indique que ces actions ont été émises en tant que rémunération pour services rendus en qualité d’administratrice indépendante. Le formulaire 4 montre qu’une seule personne a fait la déclaration et inclut l’adresse de la personne déclarant à Carmel, IN.
Kristin Ferge, Direktorin von Neuraxis, Inc. (NRXS), meldete am 17.01.2025 den nicht-derivativen Erwerb von Stammaktien. Sie erwarb 13.157 Aktien zu je $2,85. Nach dieser Transaktion hielt Frau Ferge wirtschaftlich 14.340 Aktien. In der Meldung heißt es, die Aktien seien als Vergütung für erbrachte Leistungen in ihrer Funktion als unabhängige Direktorin ausgegeben worden. Das Formular 4 weist eine meldende Person aus und enthält die Adresse der meldenden Person in Carmel, IN.
- Shares issued as director compensation align the reporting person’s interests with shareholders
- Timely disclosure of the acquisition on Form 4 provides transparency into insider ownership changes
- None.
Insights
TL;DR: Director received stock compensation, aligning her financial interest with shareholders without indicating material control changes.
This Form 4 documents a routine director compensation grant: 13,157 shares issued as payment for independent director services. Such equity awards are common and serve to align a director’s incentives with shareholder performance. The report shows a modest post-transaction holding of 14,340 shares, suggesting the grant represents a material portion of her reported holdings but does not by itself change governance control or signal a significant shift in insider ownership.
TL;DR: Insider acquisition via compensation is a neutral disclosure; transaction size appears routine for director pay.
The transaction is recorded as an acquisition at $2.85 per share on 01/17/2025, with shares issued rather than purchased on the open market. As a compensation issuance, this does not reflect a director-initiated market purchase and therefore is less indicative of a personal investment conviction. The disclosure is timely and provides transparency on changes in beneficial ownership.
Kristin Ferge, membro del consiglio di amministrazione di Neuraxis, Inc. (NRXS), ha comunicato un acquisto non derivato di azioni ordinarie in data 17/01/2025. Ha acquisito 13.157 azioni al prezzo di $2,85 ciascuna. Dopo l’operazione, la Sig.ra Ferge deteneva beneficiariamente 14.340 azioni. Il documento specifica che le azioni sono state emesse come compenso per servizi resi in qualità di amministratore indipendente. Il Form 4 indica un solo soggetto dichiaratore e riporta l’indirizzo del dichiarante a Carmel, IN.
Kristin Ferge, directora de Neuraxis, Inc. (NRXS), informó una adquisición no derivada de acciones ordinarias el 17/01/2025. Adquirió 13.157 acciones a $2,85 por acción. Tras la operación, la Sra. Ferge poseía beneficiariamente 14.340 acciones. La presentación indica que estas acciones se emitieron como compensación por servicios prestados como directora independiente de la compañía. El Formulario 4 muestra que la presentación la realiza una sola persona informante e incluye su dirección en Carmel, IN.
Kristin Ferge, Neuraxis, Inc. (NRXS)의 이사로서 2025-01-17에 비파생(비파생성) 보통주 취득을 신고했습니다. 그녀는 주당 $2.85에 13,157주를 취득했습니다. 이 거래 후 Ferge 여사는 14,340주를 실질적으로 보유하게 되었습니다. 제출서에는 이 주식이 회사의 독립 이사로서 제공한 서비스에 대한 보수로 발행되었다고 명시되어 있습니다. Form 4는 한 명의 보고자가 제출했음을 표시하며 보고자의 주소가 인디애나주 카멜(Carmel, IN)로 기재되어 있습니다.
Kristin Ferge, administratrice de Neuraxis, Inc. (NRXS), a déclaré une acquisition non dérivée d’actions ordinaires le 17/01/2025. Elle a acquis 13 157 actions au prix de 2,85 $ par action. À l’issue de la transaction, Mme Ferge détenait bénéficiairement 14 340 actions. Le document indique que ces actions ont été émises en tant que rémunération pour services rendus en qualité d’administratrice indépendante. Le formulaire 4 montre qu’une seule personne a fait la déclaration et inclut l’adresse de la personne déclarant à Carmel, IN.
Kristin Ferge, Direktorin von Neuraxis, Inc. (NRXS), meldete am 17.01.2025 den nicht-derivativen Erwerb von Stammaktien. Sie erwarb 13.157 Aktien zu je $2,85. Nach dieser Transaktion hielt Frau Ferge wirtschaftlich 14.340 Aktien. In der Meldung heißt es, die Aktien seien als Vergütung für erbrachte Leistungen in ihrer Funktion als unabhängige Direktorin ausgegeben worden. Das Formular 4 weist eine meldende Person aus und enthält die Adresse der meldenden Person in Carmel, IN.
FAQ
What transaction did Kristin Ferge report on Form 4 for NRXS?
How many Neuraxis shares does Kristin Ferge beneficially own after the reported transaction?
Why were the shares issued to Kristin Ferge?
Was the Form 4 filed by more than one reporting person?
What price per share was reported for the issuance?
